Volkan-Salancı Bilge, Kıratlı Pınar Özgen
Hacettepe University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey Phone: +90 312 305 13 36 E-mail:
Mol Imaging Radionucl Ther. 2015 Jun 5;24(2):47-59. doi: 10.4274/mirt.76476.
Both benign and malignant diseases of the thyroid are rare in the pediatric and adolescent population, except congenital hypothyroidism. Nuclear medicine plays a major role, both in the diagnosis and therapy of thyroid pathologies. Use of radioactivity in pediatric population is strictly controlled due to possible side effects such as secondary cancers; therefore, management of pediatric patients requires detailed literature knowledge. This article aims to overview current algorithms in the management of thyroid diseases and use of radionuclide therapy in pediatric and adolescent population.
除先天性甲状腺功能减退症外,甲状腺的良性和恶性疾病在儿童和青少年人群中均较为罕见。核医学在甲状腺疾病的诊断和治疗中都发挥着重要作用。由于可能产生如继发性癌症等副作用,儿科人群中放射性物质的使用受到严格控制;因此,儿科患者的管理需要详细的文献知识。本文旨在概述当前甲状腺疾病管理的算法以及放射性核素治疗在儿童和青少年人群中的应用。